Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
FAST score
Description:
A clinical risk or diagnostic score; the titles suggest a liver-disease score but also use the term for other scoring systems.
Primary topic:
Liver Disease Diagnosis and Treatment (67%)
Related topics:
Liver Disease Diagnosis and Treatment (67%),
Acute Ischemic Stroke Management (10%)
OpenAlex ID:
keywords/fast-score
Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease
2024
·
David Marti-Aguado
, José Luis Calleja
, et al.
·
Journal of Hepatology
·
252
PDF
Clinical Selection Strategies to Identify Ischemic Stroke Patients With Large Anterior Vessel Occlusion: Results From SITS-ISTR (Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry)
2017
·
Jan F. Scheitz
, Azmil H. Abdul-Rahim
, et al.
·
Stroke
·
143
PDF
Prospective cohort study of adverse events in older people admitted to the acute general hospital: risk factors and the impact of dementia
2011
·
L. Watkin
, M. R. Blanchard
, et al.
·
International Journal of Geriatric Psychiatry
·
131
A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism
2014
·
Merle Tschepe
, Valerie Seeber
, et al.
·
Thrombosis and Haemostasis
·
100
The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients
2017
·
Joaquín Cubiella
, Jayne Digby
, et al.
·
International Journal of Cancer
·
87
PDF
The use of FAST and ABCD2 scores in posterior circulation, compared with anterior circulation, stroke and transient ischemic attack: Table 1
2011
·
G Gulli
, H S Markus
·
Journal of Neurology Neurosurgery & Psychiatry
·
80
An assessment of direct and indirect costs of dementia in Brazil
2018
·
Ceres Ferretti
, Flávia M. Sarti
, et al.
·
PLoS ONE
·
71
PDF
An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis
2024
·
Basile Njei
, Eri Osta
, et al.
·
Scientific Reports
·
69
PDF
The Effectiveness of Public and Private Sector Summary Risk Measures in Predicting Insurer Insolvencies
2002
·
Steven W. Pottier
, David W. Sommer
·
Journal of Financial Services Research
·
61
Prevalence of High-risk Nonalcoholic Steatohepatitis (NASH) in the United States: Results From NHANES 2017–2018
2021
·
Eduardo Vilar-Gomez
, Raj Vuppalanchi
, et al.
·
Clinical Gastroenterology and Hepatology
·
60
PDF
Stroke Mimics in a Stroke Care Pathway Based on MRI Screening
2016
·
Véronique Quenardelle
, Valérie Lauer-Ober
, et al.
·
Cerebrovascular Diseases
·
56
Validation of the accuracy of the FAST™ score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
2022
·
Tinsay A. Woreta
, Mark L. Van Natta
, et al.
·
PLoS ONE
·
50
PDF
Research advances in the diagnosis and treatment of MASLD/MASH
2024
·
Dekai Wang
, Jinxian Miao
, et al.
·
Annals of Medicine
·
47
Symptom or faecal immunochemical test based referral criteria for colorectal cancer detection in symptomatic patients: a diagnostic tests study
2018
·
Jesús-Miguel Herrero
, Pablo Vega
, et al.
·
BMC Gastroenterology
·
43
PDF
Effect of 48‐week pemafibrate on non‐alcoholic fatty liver disease with hypertriglyceridemia, as evaluated by the FibroScan‐ aspartate aminotransferase score
2021
·
Takeshi Hatanaka
, Takashi Kosone
, et al.
·
JGH Open
·
41
PDF
Pemafibrate improves liver dysfunction and non-invasive surrogates for liver fibrosis in patients with non-alcoholic fatty liver disease with hypertriglyceridemia: a multicenter study
2022
·
Asahiro Morishita
, Kyoko Oura
, et al.
·
Hepatology International
·
39
PDF
Randomised clinical trial: Design of the SYNERGY‐NASH phase 2b trial to evaluate tirzepatide as a treatment for metabolic dysfunction‐associated steatohepatitis and modification of screening strategy to reduce screen failures
2024
·
Raj Vuppalanchi
, Rohit Loomba
, et al.
·
Alimentary Pharmacology & Therapeutics
·
38
Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study
2022
·
Brooke A. Rice
, Timothy S. Naimi
, et al.
·
Clinical Gastroenterology and Hepatology
·
33
PDF
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination
2020
·
Valentin Blank
, David Petroff
, et al.
·
Scientific Reports
·
33
PDF
Association between steatohepatitis biomarkers and hepatocellular carcinoma after hepatitis C elimination
2020
·
Eiichi Ogawa
, Koji Takayama
, et al.
·
Alimentary Pharmacology & Therapeutics
·
32
Definition of tachycardia for risk stratification of pulmonary embolism
2020
·
Lukas Hobohm
, Cecilia Becattini
, et al.
·
European Journal of Internal Medicine
·
31
PDF
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models
2024
·
Cecilia Becattini
, Maria Cristina Vedovati
, et al.
·
Journal of Thrombosis and Haemostasis
·
30
PDF
Appraisal of the faecal haemoglobin, age and sex test (FAST) score in assessment of patients with lower bowel symptoms: an observational study
2019
·
Jayne Digby
, Judith A. Strachan
, et al.
·
BMC Gastroenterology
·
29
PDF
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter Study
2024
·
Gong Feng
, Ferenc E. Mózes
, et al.
·
Clinical Gastroenterology and Hepatology
·
25
FAST and Agile–the MASLD drift: Validation of Agile 3+, Agile 4 and FAST scores in 246 biopsy-proven NAFLD patients meeting MASLD criteria of prevalent caucasian origin
2024
·
Madalina-Gabriela Taru
, Cristian Tefas
, et al.
·
PLoS ONE
·
24
Show more works
View as search
Works count:
186
Citation count:
2,196
Year
Topic
Type